Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-041642
Filing Date
2025-03-18
Accepted
2025-03-18 20:02:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11659
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 48922
  Complete submission text file 0000950170-25-041642.txt   80961
Mailing Address TWO GREENWICH PLAZA, SUITE 1 GREENWICH CT 06830
Business Address TWO GREENWICH PLAZA, SUITE 1 GREENWICH CT 06830 (203) 542-4000
Silver Point Capital L.P. (Filed by) CIK: 0001332784 (see all company filings)

EIN.: 223844936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1227
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-87833 | Film No.: 25750456
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)